Pros | 5Y returns in the top 25% of the category. 3Y returns in the top 25% of the category. Beats FD returns for both 3Y & 5Y duration. | Larger AUM within category. Beats FD returns for both 3Y & 5Y. | ||
Cons | - | - |
INDMoney rank | - | 5/20 | ||
Category,Subcateogry | Equity,Mid-Cap | Equity,Mid-Cap | ||
Fund Age | 7 Years | 12 Years | ||
Fund Size | 3994 Cr | 58300 Cr | ||
Min Investment | SIP ₹500 Lumpsum ₹1000 | SIP ₹100 Lumpsum ₹100 | ||
Expense Ratio | 0.46% | 0.37% | ||
Exit Load | 1% | 1% | ||
Benchmark Index | Nifty Midcap 150 TR INR | Nifty Midcap 150 TR INR |
No of Holdings | 65 | 65 | ||
Top 5 Holdings | Glenmark Pharmaceuticals Ltd (3.11%) Indian Bank (2.99%) UNO Minda Ltd (2.58%) Blue Star Ltd (2.53%) Tube Investments of India Ltd Ordinary Shares (2.39%) | Fortis Healthcare Ltd (4.11%) GE Vernova T&D India Ltd (3.94%) Dixon Technologies (India) Ltd (3.09%) Mphasis Ltd (3%) Vishal Mega Mart Ltd (2.83%) | ||
No of Sectors | 11 | 12 | ||
Top 3 Sectors | Industrial (20.35%) Financial Services (19.12%) Health (15.65%) | Financial Services (19%) Consumer Cyclical (17.8%) Industrial (16.08%) | ||
Equity % | 97.88% | 98.12% | ||
Debt % | - | - | ||
P/E | 26.3 | 29.53 | ||
P/B | 3.8 | 4.91 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | 4.2% | 2.4% | ||
3-Month Return | 3.68% | 1.99% | ||
6-Month Return | 9.51% | 15.25% | ||
1-Year Return | 2.8% | 7.29% | ||
3-Year Return | 25.47% | 23.35% | ||
5-Year Return | 29.66% | 28.7% |
Sharpe | 1.1 | 1.02 | ||
Alpha | 2.13 | 1.5 | ||
Beta | 0.96 | 0.89 | ||
Standard Deviation | 15.33 | 15.03 | ||
Information Ratio | 0.6 | -0.05 |
Description | Mahindra Manulife Mid Cap Fund Direct Growth is an equity fund.The fund could potentially beat inflation in the long-run. | Kotak Midcap Fund Direct Growth is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Manish Lodha,Kirti Dalvi,Krishna Sanghavi | Atul Bhole |